- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Saykara attracts Nuance in acquisition deal
The medical documentation tool developer has been acquired by Nuance Communications having raised $7.5m from investors including NewYork-Presbyterian.
Feb 12, 2021Phable tells of $12m series A
Phable, developer of a chronic disease assistance app, has secured funding in a round led by healthcare provider Manipal Hospitals.
Feb 12, 2021Autocrypt authorises series A round
Penta Security's V2X security software spinoff received nearly $13m from investors including IBK, Kookmin Bank and Hyundai Venture Investment Corp.
Feb 12, 2021C-Zero seizes series A cash
The gas-to-hydrogen technology developer bagged $11.5m in a round co-led by Eni Next and backed by Mitsubishi Heavy Industries.
Feb 12, 2021Plus adds $200m in funding
Wanxiang International Investment co-led a round for the automated trucking system developer that included existing backer Full Truck Alliance.
Feb 11, 2021Day One progresses to $130m series B
Access Biotechnology returned for a round that will push Day One Biopharmaceuticals' paediatric drug candidate through a phase 2 study.
Feb 11, 2021Daily deal net: February 11, 2021
Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.
Feb 11, 2021RapidSOS rescues $85m in series C round
The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.
Feb 11, 2021Armis arms itself with $125m
CapitalG took part in a round that valued the cybersecurity software provider at $2bn and came just over a year after it was acquired for $1.1bn.
Feb 11, 2021PGDx picks up $103m in series C
The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.
Feb 11, 2021Notch marks $85m series A round
Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.
Feb 11, 2021Drug Farm harvests $56m
The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.
Feb 11, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


